Drug Shortage Report for HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION
Report ID | 1703 |
Drug Identification Number | 00872539 |
Brand name | HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION |
Common or Proper name | HYDROCORTISONE SODIUM SUCCINATE |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HYDROCORTISONE |
Strength(s) | 250MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 10 |
ATC code | H02AB |
ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2016-02-29 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2017-10-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-03-13 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v3 | 2017-03-13 | English | Compare |
v4 | 2017-03-13 | French | Compare |
Showing 1 to 4 of 4